|
Name |
Pyrenosetin B
|
Molecular Formula | C25H35NO5 | |
IUPAC Name* |
(2R,3R,3aS,5'R,5aR,7S,9aS,9bR)-3-[(3R)-3-hydroxybut-1-enyl]-5'-(hydroxymethyl)-1',4,7,9b-tetramethylspiro[3,3a,5a,6,7,8,9,9a-octahydrocyclopenta[a]naphthalene-2,3'-pyrrolidine]-1,2',4'-trione
|
|
SMILES |
C[C@H]1CC[C@H]2[C@H](C1)C=C([C@H]3[C@@]2(C(=O)[C@]4([C@@H]3C=C[C@@H](C)O)C(=O)[C@H](N(C4=O)C)CO)C)C
|
|
InChI |
InChI=1S/C25H35NO5/c1-13-6-8-17-16(10-13)11-14(2)20-18(9-7-15(3)28)25(22(30)24(17,20)4)21(29)19(12-27)26(5)23(25)31/h7,9,11,13,15-20,27-28H,6,8,10,12H2,1-5H3/t13-,15+,16+,17-,18+,19+,20+,24+,25-/m0/s1
|
|
InChIKey |
JBZGVPJZPTUTAU-OMXSNZPGSA-N
|
|
Synonyms |
Pyrenosetin B
|
|
CAS | NA | |
PubChem CID | 156581892 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 429.5 | ALogp: | 2.7 |
HBD: | 2 | HBA: | 5 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 94.9 | Aromatic Rings: | 4 |
Heavy Atoms: | 31 | QED Weighted: | 0.531 |
Caco-2 Permeability: | -4.937 | MDCK Permeability: | 0.00001920 |
Pgp-inhibitor: | 0.933 | Pgp-substrate: | 0.984 |
Human Intestinal Absorption (HIA): | 0.185 | 20% Bioavailability (F20%): | 0.008 |
30% Bioavailability (F30%): | 0.078 |
Blood-Brain-Barrier Penetration (BBB): | 0.743 | Plasma Protein Binding (PPB): | 63.15% |
Volume Distribution (VD): | 0.882 | Fu: | 41.62% |
CYP1A2-inhibitor: | 0.014 | CYP1A2-substrate: | 0.558 |
CYP2C19-inhibitor: | 0.063 | CYP2C19-substrate: | 0.875 |
CYP2C9-inhibitor: | 0.023 | CYP2C9-substrate: | 0.123 |
CYP2D6-inhibitor: | 0.002 | CYP2D6-substrate: | 0.047 |
CYP3A4-inhibitor: | 0.772 | CYP3A4-substrate: | 0.86 |
Clearance (CL): | 8.664 | Half-life (T1/2): | 0.508 |
hERG Blockers: | 0.011 | Human Hepatotoxicity (H-HT): | 0.296 |
Drug-inuced Liver Injury (DILI): | 0.793 | AMES Toxicity: | 0.014 |
Rat Oral Acute Toxicity: | 0.326 | Maximum Recommended Daily Dose: | 0.056 |
Skin Sensitization: | 0.595 | Carcinogencity: | 0.611 |
Eye Corrosion: | 0.011 | Eye Irritation: | 0.012 |
Respiratory Toxicity: | 0.955 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
D0E9KA | 0.260 | ||||||
D0I5DS | 0.248 | ||||||
D0W2EK | 0.238 | ||||||
D04SFH | 0.238 | ||||||
D0IL7L | 0.222 | ||||||
D0IX6I | 0.222 | ||||||
D06AEO | 0.222 | ||||||
D0I1LH | 0.220 | ||||||
D0CZ1Q | 0.219 | ||||||
D0D2TN | 0.219 |